| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/24/2010 | WO2010046917A3 Fludarabine phosphate composition |
| 06/24/2010 | WO2010025324A3 Nanoparticles for immunotherapy |
| 06/24/2010 | WO2010019649A3 Active polymer compositions |
| 06/24/2010 | WO2010018596A3 Stable injectable oil-in-water docetaxel nanoemulsion |
| 06/24/2010 | WO2010017433A3 Use of sucralose as a granulating agent |
| 06/24/2010 | WO2010007312A3 Method of manufacturing cellular films directly |
| 06/24/2010 | WO2009151788A3 Universal anchor peptide for nanoparticles |
| 06/24/2010 | WO2009122187A3 Pharmaceutical composition |
| 06/24/2010 | US20100160895 Apparatus and Method for Transdermal Delivery of Parathyroid Hormone Agents |
| 06/24/2010 | US20100160437 Topical composition comprising a cyclofructan, a carrier and a drug |
| 06/24/2010 | US20100160400 Treatment using dantrolene |
| 06/24/2010 | US20100160211 Glycopeptide phosphonate derivatives |
| 06/24/2010 | US20100159593 Transfection reagents |
| 06/24/2010 | US20100159592 Emulsion compositions |
| 06/24/2010 | US20100159589 Nestin-expressing hair follicle stem cells |
| 06/24/2010 | US20100159026 Colonic purgative composition with soluble binding agent |
| 06/24/2010 | US20100159021 Small Molecule Ligands of the Integrin RGD Recognition Site and Methods of Use |
| 06/24/2010 | US20100159020 Polymeric micelles for drug delivery |
| 06/24/2010 | US20100159019 Micelles For Drug Delivery |
| 06/24/2010 | US20100159018 Venlafaxine Formulations and Methods of Preparing the Same |
| 06/24/2010 | US20100159017 Composition of biocompatible microparticles of alginic acid for the controlled release of active ingredients by intravenous administration |
| 06/24/2010 | US20100159016 Pain relief composition comprising paramagnetic silver nanoparticles |
| 06/24/2010 | US20100159015 Systems and Methods to Treat Pain Locally |
| 06/24/2010 | US20100159014 Polymeric micellar clusters and their uses in formulating drugs |
| 06/24/2010 | US20100159013 flavored clay-based therapeutic composition |
| 06/24/2010 | US20100159012 Conjugates of Therapeutically Active Compounds |
| 06/24/2010 | US20100159011 Compositions For Biomedical Applications |
| 06/24/2010 | US20100159010 Active Agent Formulations, Methods of Making, and Methods of Use |
| 06/24/2010 | US20100159009 Controlled-release formulations |
| 06/24/2010 | US20100159008 Hydrogels, methods of making hydrogels, methods of using hydrogels, and methods of isolating, trapping, attracting, and/or killing cancer cells |
| 06/24/2010 | US20100159007 Pharmaceutical compositions for transmucosal delivery of a therapeutically active agent on the basis of submicron particles |
| 06/24/2010 | US20100159006 Improved antimicrobial peptides |
| 06/24/2010 | US20100159005 COMBINATION OF TRIAZINE DERIVATIVES AND PPARalpha AGONISTS |
| 06/24/2010 | US20100159004 Methods and compositions for reduction of side effects of therapeutic treatments |
| 06/24/2010 | US20100159003 Process for the preparation of a medicament comprising vardenafil hydrochloride trihydrate |
| 06/24/2010 | US20100159002 Dosage form comprising therapeutic formulation |
| 06/24/2010 | US20100159001 Extended-Release Pharmaceutical Formulations |
| 06/24/2010 | US20100159000 Medicine for treating gastrointestinal disorder including fecal incontinence |
| 06/24/2010 | US20100158999 Combination of triazine derivatives and hmg-coa reductase inhibitors |
| 06/24/2010 | US20100158998 Formulations comprising vitamin d or derivatives thereof |
| 06/24/2010 | US20100158997 Blow-molded thin-walled drug delivery capsules |
| 06/24/2010 | US20100158996 Ester compound and medical use thereof |
| 06/24/2010 | US20100158995 Systems for delivery and release of angiotensin-(1-7) |
| 06/24/2010 | US20100158994 Nanoparticles for Delivery of Therapeutic Agents Using Ultrasound and Associated Methods |
| 06/24/2010 | US20100158993 Topical Gel Compositions |
| 06/24/2010 | US20100158992 Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors |
| 06/24/2010 | US20100158991 Patch package structure |
| 06/24/2010 | US20100158990 Transdermal method and patch for corticosteroid administration |
| 06/24/2010 | US20100158989 Hemostatic Agent Composition, Delivery System and Method |
| 06/24/2010 | US20100158988 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 06/24/2010 | US20100158987 Adhesive Label With Bittering Agent and Fluidifying Agents for Natural Airway Secretions |
| 06/24/2010 | US20100158986 Personal Care Composition Providing Quietness and Softness Enhancement, Methods of Preparing and Articles Using the Same |
| 06/24/2010 | US20100158985 Porous structures of microbial-derived cellulose for in vivo implantation |
| 06/24/2010 | US20100158984 Encapsulates |
| 06/24/2010 | US20100158982 Sheet for guiding regeneration of mesenchymal tissue and production method thereof |
| 06/24/2010 | US20100158979 Temporal release of growth factors from 3d micro rod scaffolds for tissue regeneration |
| 06/24/2010 | US20100158978 Bioactive spray coating compositions and methods of making and uses thereof |
| 06/24/2010 | US20100158976 Collagen/hydroxyapatite composite scaffold, and process for the production thereof |
| 06/24/2010 | US20100158974 Coated implant |
| 06/24/2010 | US20100158972 Method for reducing the likelihood of preterm labor in a subject in need thereof |
| 06/24/2010 | US20100158971 Method for reducing the likelihood of preeclampsia in a subject in need thereof |
| 06/24/2010 | US20100158970 Implantable composites and implants comprising same |
| 06/24/2010 | US20100158968 Cell-permeant peptide-based inhibitor of kinases |
| 06/24/2010 | US20100158964 Personal Care Composition Providing Quietness and Softness Enhancement and Articles Using the Same |
| 06/24/2010 | US20100158959 Stable Combinations of Amlodipine Besylate and Benazepril Hydrochloride |
| 06/24/2010 | US20100158958 Gastric reflux resistant dosage forms |
| 06/24/2010 | US20100158957 Aerosolized fluoroquinolones and uses thereof |
| 06/24/2010 | US20100158956 Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement |
| 06/24/2010 | US20100158928 Immune response modifier compositions and methods |
| 06/24/2010 | US20100158854 Method for treatment of airway and apparatus and kit for use therewith |
| 06/24/2010 | US20100158820 Xylitol dental maintenance system |
| 06/24/2010 | US20100158819 Calcium Glycerophosphate for Treating and Preventing Respiratory Diseases or Conditions |
| 06/24/2010 | US20100158818 Antimicrobial n-chlorinated compositions |
| 06/24/2010 | US20100158805 Quantum dot labeled stem cells for use in cardiac repair |
| 06/24/2010 | CA2756091A1 A microencapsulation process of sertoli cells, microcapsules obtained and their use for prevention and cure of type 1 diabetes mellitus |
| 06/24/2010 | CA2750369A1 Pressure-sensitive adhesive tape package |
| 06/24/2010 | CA2747679A1 Oral dispersible tablet |
| 06/24/2010 | CA2747345A1 Precompacted fast-disintegrating formulations of compounds with a low oral bioavailability |
| 06/24/2010 | CA2747314A1 Treatment of vaginal atrophy in women with cardiovascular pathology risk |
| 06/24/2010 | CA2747311A1 Solid composition containing the ingredient rasagiline |
| 06/24/2010 | CA2746888A1 Misuse preventative, controlled release formulation |
| 06/24/2010 | CA2746464A1 Melt-coated pharmaceutical composition with fast release |
| 06/24/2010 | CA2746190A1 Controlled-release composition for producing sustained-release preparation containing udenafil |
| 06/24/2010 | CA2746052A1 Delivery system for delivery of a substance into the oral cavity |
| 06/24/2010 | CA2745279A1 Capecitabine rapidly disintegrating tablets |
| 06/24/2010 | CA2743980A1 Thioic acids as building block for polythioesters |
| 06/24/2010 | CA2737335A1 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
| 06/23/2010 | EP2199402A1 Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof |
| 06/23/2010 | EP2199299A2 Antisense modulation of survivin expression |
| 06/23/2010 | EP2199298A1 Sirna silencing of Apolipoprotein B |
| 06/23/2010 | EP2199281A1 Thioic acids as building block for polythioesters |
| 06/23/2010 | EP2198888A2 Sustained release of microcrystalline peptide suspensions |
| 06/23/2010 | EP2198885A1 Calcium phosphate nanoparticles as dye carrier for photodynamic therapy |
| 06/23/2010 | EP2198859A1 Melt-coated pharmaceutical composition with fast release |
| 06/23/2010 | EP2198858A1 Sustained release preparation of a macrolide compound like tacrolimus |
| 06/23/2010 | EP2198857A1 Oral dispersible tablet |
| 06/23/2010 | EP2198856A1 Process for preparing granular compositions |
| 06/23/2010 | EP2198855A1 Dried milled granulate and methods |
| 06/23/2010 | EP2198854A2 Sustained-release liposomal anesthetic compositions |
| 06/23/2010 | EP2198817A1 Patch package structure |